Described herein are pharmaceutical packaging units which reduce oxidative degradation of morphine, hydromorphone, promethazine together with other oxygen-sensitive medicines, this kind of units such as a syringe by having an oxygen permeable tip cap, a hermetically sealed oxygen barrier blister packaging with extremely small permeability to oxygen